We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Settles Celebrex Patent Suit, Is Poised to Launch All Strengths
Mylan Settles Celebrex Patent Suit, Is Poised to Launch All Strengths
Generic firm Mylan said June 2 that it had reached a settlement with Pfizer to market versions of Celebrex (celecoxib), marking the latest twist in the generic conversion of the blockbuster arthritis pain drug.